Veterinary Medicines

Lactovac Suspension for injection

Not authorised
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
Download as PDF

Product identification

Medicine name:
Lactovac Suspension for injection
Lactovac Suspension injectable
Active substance:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine coronavirus, strain 800, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine rotavirus A, strain Holland, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine rotavirus A, strain 1005/78, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Revoked
Authorised in:
  • Luxembourg
Package description:
  • Type I glass vial containing 5 ml. The glass vial is closed with a type I rubber stopper, sealed with an aluminium crimp cap. Cardboard box with 10 glass vials of 1 dose (5 ml).
  • Type I glass vial containing 25 ml. The glass vial is closed with a type I rubber stopper, sealed with an aluminium crimp cap. Cardboard box with 1 glass vial of 5 doses (25 ml).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 087/91/11/0342
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0417/001
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."